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High-mobility  group  box  1  (HMGB1)  protein  was  initially 
found to be a DNA-binding protein present in almost all eukary-
otic cells, where it stabilizes nucleosome formation and acts as 
a nuclear  factor  that enhances  transcription  (3, 4). Recently, 
HMGB1 has been demonstrated to play crucial roles in response 
to tissue damage, indicating that HMGB1 is a prototype of the 








































IFN-γ production of NKT cells and Gr-1+CD11b+ cells in the liver receiv-
ing islets is inhibited by anti-HMGB1 antibody. Next, we determined 
whether anti-HMGB1 antibody treatment has any effect on IFN-γ 
Figure 1
Essential roles of HMGB1 in early loss of transplanted islets. (A) Nonfasting plasma glucose levels in STZ-induced diabetic mice received 200 
syngeneic islets (top panel) and those treated with chicken anti-HMGB1 antibody or control chicken IgG. Individual lines represent glucose levels 
of each animal. (B) FACS profiles of liver MNCs from naive mice, STZ-induced diabetic mice that received 200 syngenic islets (Islet Tx), and 
islet transplanted mice treated with anti-HMGB1 antibody or with chicken IgG. NKT cells (top 2 rows) and Gr-1+CD11b+ cells (bottom 2 rows) 
were analyzed for IFN-γ (second and fourth rows). The numbers in the figures represent the percentage of cells in the corresponding square 
areas. Representative data from 4 experiments are shown. (C) FACS profiles of NKT cells and Gr-1+CD11b+ cells after HMGB1 treatment. Liver 
MNCs from wild-type or Jα18–/– mice treated with i.v. injection of saline or HMGB1 (100 μg/mouse) were isolated 2 hours after the injection and 
examined by flow cytometry for IFN-γ production by NKT cells and Gr-1+CD11b+ cells. The numbers in the figures represent the percentage of 
cells in the corresponding square areas. Representative data from 4 experiments are shown.
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NKT cell–dependent IFN-γ production by Gr-1+CD11b+ cells upon stim-















Involvement of TLR2 and RAGE but not TLR4 in HMGB1-dependent 
















Pancreatic islet cells are a major source of HMGB1, which mediates 

















HMGB1 receptors involved in early loss of transplanted islets. (A) In vitro cytokine production by liver MNCs. Liver MNCs (2 × 106/well) isolated 
from wild-type, Tlr2–/–, Tlr4–/–, or Rage–/– mice were cultured with indicated doses of HMGB1 in vitro for 48 hours, and IL-12 or IFN-γ levels in the 
culture supernatant were measured. Representative data from 2 experiments are shown. (B) Nonfasting plasma glucose levels of STZ-induced 
diabetic wild-type, Tlr2–/–, Tlr4–/–, or Rage–/– mice that received 200 syngeneic islets. Individual lines represent the glucose level of each animal.
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HMGB1 production in tissues and cell types. (A) Photomicrographs of islets. Islet cells 3 hours after transplantation in the liver (top row) and those 
of naive pancreas or isolated islets were examined. Sections stained with anti-insulin or anti-HMGB1 followed by staining with hematoxylin are 
shown. In general, HMGB1 was detected in the nucleus (brown), while some was detected in cytoplasm, as indicated by arrowheads. Original 
magnification: ×100 (first and second columns) and ×800 (third column). Boxed regions in the second column were enlarged. (B) HMGB1 contents 
(ng/μg DNA) of individual organs (n = 5), isolated islets, or FACS-sorted liver MNCs (n = 3). (C) Left panels: Fluorescence photomicrographs of 
isolated islets (original magnification, ×200) stained with HO 342 (blue) and PI (red) at 24 hours after in vitro culture with or without IFN-γ, TNF-α, 
and IL-1β (20 ng/ml each) or IL-10 (20 ng/ml). Right panels: HMGB1 levels in the culture (200 cells/dish) were also measured at the indicated time 
points in the absence of cytokine or the presence of cytokine mixtures or of control cytokine (IL-10). The values are expressed as the mean ± SD 
in each group (n = 5). (D) Serum HMGB1 levels were measured after STZ injection and also after transplantation of 400 syngeneic islets, which 
had been performed 72 hours after STZ injection (n = 5–6). The values are expressed as the mean ± SD. *P < 0.05; **P < 0.01.
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NKT cell–dependent IL-12 and IFN-γ production by liver MNCs in response to HMGB1. (A) Liver MNCs (2 × 106/well) isolated from wild-type 
or Jα18–/– mice were cultured with the indicated doses of HMGB1 in vitro for 48 hours and measured for IL-12 and IFN-γ. Representative 
data from 2 experiments are shown. (B) PCR analysis on HMGB1 receptors. FACS-sorted liver MNCs (2 × 103 for Tlr2, Rage, or Hprt) were 
analyzed for mRNA levels by quantitative real-time PCR. Data were analyzed by the ΔΔCt method using the expression level in Mo/Mφ as nor-
malized control. (C) Cytokine production in FACS-sorted liver MNCs upon stimulation with HMGB1. FACS-sorted cells were cultured in vitro 
(1 × 105 cells/well) for 48 hours in the presence of HMGB1 (20 μg/ml). The amounts of IL-12 and IFN-γ were measured by CBA (n = 3). (D) 
Cytokine production by DCs, Mo/Mφ, or Neu in the presence of NKT cells. FACS-sorted Gr-1–CD11b+CD11c+ DCs, Gr-1–CD11b+CD11c– Mo/Mφ, 
and Gr-1+CD11b+CD11c– Neu (4 × 104) were cocultured in vitro with NKT cells (2 × 105) in the presence of HMGB1 (20 μg/ml) for 48 hours. The 
amounts of IL-12 and IFN-γ were measured by CBA (n = 3). (E) Intracellular cytokine staining of liver MNCs after HMGB1 treatment. Liver MNCs 
(2 × 106) were cultured with HMGB1 (20 μg/ml) for 24 hours, and the indicated cells were gated and analyzed for their production of IFN-γ by 
intracellular cytokine staining.
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Involvement of CD40-CD40L interaction in production of IL-12 and IFN-γ in early loss of transplanted islets. (A) CD40 expression in DCs and Neu 
before or after treatment with HMGB1. Liver MNCs (2 × 106) were treated without or with HMGB1 (20 μg/ml) for 24 hours and analyzed for CD40 
expression (n = 3). (B) Requirement of CD40-CD40L interaction in the production of IL-12 and IFN-γ in the presence of NKT cells. DCs or Neu 
(4 × 104) were cocultured in vitro with NKT cells (2 × 105) in the presence of HMGB1 (20 μg/ml) for 48 hours with or without addition of anti-CD40L 
antibody. IL-12 and IFN-γ levels were measured by CBA (n = 3). The values are expressed as the mean ± SD. *P < 0.05; **P < 0.01. (C) Nonfasting 
plasma glucose levels of STZ-induced diabetic mice that had received 200 syngeneic islets and were treated with control goat IgG or goat anti-
mouse IL-12 antibody and those with control hamster IgG or hamster anti-mouse CD40L antibody with 200 μg intraperitoneal injection per mouse 
at the time of transplantation. Individual lines represent the nonfasting plasma glucose levels of each diabetic mouse after islet transplantation.
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patients  with  type  1  diabetes  mellitus  using  a 
glucocorticoid-free immunosuppressive regimen.  
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